AUR108

· Aurigene Discovery Technologies Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AUR108, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1) [Phase 1]

See pricing